159275-16-8

Basic information

• Product Name: 4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester
• Synonyms: 1-Cbz-4-(MethylsulfonyloxyMethyl)piperidine;1-Cbz-4-(mesyloxymethyl)piperidine;Benzyl 4-(((methylsulfonyl);4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester;4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester, 98 %;Benzyl 4-(((Methylsulfonyl)oxy)Methyl)piperidine-1-carboxylate
• CAS NO: 159275-16-8
• Molecular Formula: C₁₅H₂₁NO₅S
• Molecular Weight: 327.39594
• Mol File: 159275-16-8.mol

Chemical Properties

• Boiling Point: 500.5±33.0 °C(Predicted)
• Appearance: /
• Density: 1 +-.0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: -2.01±0.40(Predicted)
• CAS DataBase Reference: 4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester(159275-16-8)
• EPA Substance Registry System: 4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester(159275-16-8)

Safety Data

• Hazardous Substances Data: 159275-16-8(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester is used as a reagent in organic synthesis for its ability to protect amines, which is crucial in various chemical reactions to prevent unwanted side reactions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester is utilized as a protecting group for amines in the synthesis of complex organic molecules, including potential drug candidates.
Used in Pharmaceutical Development:
4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester is employed in the development of pharmaceuticals, where its properties may contribute to the creation of new drugs with specific therapeutic effects.
Used in Agrochemical Development:
4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester also has potential applications in the development of agrochemicals, where it could be used to protect amines in the synthesis of pesticides or other agricultural chemicals.
Used in Chemical and Industrial Applications:
Depending on its specific properties and reactivity, 4-(Methanesulfonyloxymethyl)-piperidine-1-carboxylic acid benzyl ester may find use in other chemical and industrial processes, where its unique structure and functional groups can be leveraged for specific purposes.

Upstream product

• 124-63-0 methanesulfonyl chloride 
• 122860-33-7 benzyl 4-(hydroxymethyl)piperidine-N-carboxylate 
• 6457-49-4 4-piperidinemethanol 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 652130-42-2 1-benzyloxycarbonyl-4-[(5,6-dimethoxy-2-ethoxycarbonylindan-1-on-2-yl)methyl]piperidine 
• 159275-17-9 benzyl 4-(bromomethyl)tetrahydro-1-(2H)-pyridinecarboxylate 
• 1211587-42-6 benzyl 4-[(chlorosulfonyl)methyl]piperidine-1-carboxylate 
• 1355455-38-7 benzyl 4-((acetylsulfanyl)methyl)piperidine-1-carboxylate 
• 1401098-34-7 benzyl 4-((1,4-dioxaspiro[4.5]decan-8-yloxy)methyl)piperidine-1-carboxylate 
• 1401098-37-0 benzyl 4-((4-(4-(methylsulfonyl)phenyl)cyclohex-3-enyloxy)methyl)piperidine-1-carboxylate 
• 1951431-22-3 BKI-1369 

Relevant articles and documents

Unbalanced-Ion-Pair-Catalyzed Nucleophilic Fluorination Using Potassium Fluoride

An unbalanced ion pair promoter (e.g., tetrabutylammonium sulfate), consisting of a bulky and charge-delocalized cation and a small and charge-localized anion, greatly accelerates nucleophilic fluorinations using easy handling KF. We also successfully converted an inexpensive and commercially available ion-exchange resin to the polymer-supported ion pair promoter (A26–SO42–), which could be reused after filtration. Moreover, A26–SO42– can be used in continuous flow conditions. In our conditions, water is well-tolerated.

Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyrimidine-based protein kinase D inhibitors

The multiple roles of protein kinase D (PKD) in various cancer hallmarks have been repeatedly reported. Therefore, the search for novel PKD inhibitors and their evaluation as antitumor agents has gained considerable attention. In this work, novel pyrazolo[3,4-d]pyrimidine based pan-PKD inhibitors with structural variety at position 1 were synthesized and evaluated for biological activity. Starting from 3-IN-PP1, a known PKD inhibitor with IC50 values in the range of 94–108 nM, compound 17m was identified with an improved biochemical inhibitory activity against PKD (IC50 = 17–35 nM). Subsequent cellular assays demonstrated that 3-IN-PP1 and 17m inhibited PKD-dependent cortactin phosphorylation. Furthermore, 3-IN-PP1 displayed potent anti-proliferative activity against PANC-1 cells. Finally, a screening against different cancer cell lines demonstrated that 3-IN-PP1 is a potent and versatile antitumoral agent.

SUBSTITUTED PIPERIDINE COMPOUNDS

The present disclosure provides substituted piperidine compounds having Formula (I), and the pharmaceutically acceptable salts and solvates thereof, wherein R1, B, X, and Z are defined as set forth in the specification. The present disclosure i

A library of conformationally restricted saturated heterocyclic sulfonyl chlorides

An approach to the synthesis of conformationally restricted saturated heterocyclic sulfonyl chlorides is described. Being guided by the principle of diversity-oriented conformational restriction, a mini-library of saturated heterocyclic sulfonyl chlorides

CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS

Therapeutic compounds are disclosed having the general formula (I) that are useful for the treatment of metabolic disorders, including type II diabetes. The compounds have activity as agonists of GPR119. Compounds having the stereochemistry of formula (la) may also demonstrate DPP-IV inhibitory activity.

SORDARIN DERIVATIVES FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY PATHOGENIC MICROORGANISMS

This invention relates to a new sordarin derivative or a pharmaceutically acceptable salt thereof, which has antimicrobial activities (especially, antifungal activities), to process for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for prophylactic and/or therapeutic treatment of infectious diseases in a human being or an animal.

NOVEL ANTIDIABETIC COMPOUNDS HAVING HYPOLIPIDAEMIC, ANTIHYPERTENSIVE PROPERTIES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

New thiazolidin-2,4-dione derivatives of formula (1) in which A, W, Q, B, D, X, Y, Z, R', k and p are defined as in claim 1; their tautomeric forms, their derivatives, their steroisomers, their polymorphs, their pharmaceutical acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. Methods for their preparation and their use as antidiabetic compounds are claimed.

Phosphonic acid derivatives

A phosphonic acid derivative which is useful for medically treating hyperlipemia, represented by the following general formula (I) or a pharmacologically acceptable salt thereof: STR1 Representative example of the compound according to the present invention is one represented by the following formula: STR2

Heterocyclic compouds

A compound of the general formula wherein: n is 0 or 1; M1 is an amino group; Q is an aromatic heterocyclic group containing a basic nitrogen atom; M2 is an imino group; L is a template group; and A is an acidic group, or an ester or amide derivative thereof, or a sulphonamide group; and pharmaceutically acceptable salts and pro-drugs thereof, for use in the treatment of a disease in which platelet aggregation mediated by the binding of adhesion molecules to GPIIb-IIIa is involved. Novel compounds are also disclosed.